Literature DB >> 9628952

Screening for colorectal cancer.

M A Jednak1, T T Nostrant.   

Abstract

Randomized, controlled trials have shown with certainty that screening for colorectal cancer reduces morbidity and is cost-effective. Factors that increase the risk of colorectal cancer include a personal or family history of adenomatous polyps or colorectal cancer, certain genetic syndromes and chronic inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9628952     DOI: 10.1016/s0095-4543(05)70065-8

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  1 in total

1.  Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line.

Authors:  T Tokunaga; T Tsuchida; H Kijima; K Okamoto; Y Oshika; N Sawa; Y Ohnishi; H Yamazaki; S Miura; Y Ueyama; M Nakamura
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.